Sign inCreate Account
The pharmaceutical companies may suffer sales loss of Rs 3,000 crore (Rs 30 billion) if the government's span of control increases, as proposed in the new pricing policy for the medicines, a section of the industry said on Monday.
NEWS
BUSINESS
MOVIES
CRICKET
SPORTS
GET AHEAD
REDIFF MONEY
REDIFF-TV
REDIFF ASTRO